| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |